Immune globulin subcutaneous and Lorcaserin Extended-Release Tablets
Determining the interaction of Immune globulin subcutaneous and Lorcaserin Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: immune globulin subcutaneous
Brand name: Cutaquig, Cuvitru, Hizentra, Vivaglobin, Xembify
Synonyms: Immune globulin (subcutaneous)
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Immune globulin subcutaneous-Lorcaserin Hydrochloride
- Immune globulin subcutaneous-Lorcaserin Tablets
- Immune globulin subcutaneous-Lorcet
- Immune globulin subcutaneous-Lorcet Plus
- Immune globulin subcutaneous-Lorcet Tablets
- Immune globulin subcutaneous-Lorlatinib
- Lorcaserin Extended-Release Tablets-Immune globulin-ifas Intravenous
- Lorcaserin Extended-Release Tablets-Imodium
- Lorcaserin Extended-Release Tablets-Imodium A-D
- Lorcaserin Extended-Release Tablets-Imodium A-D EZ Chews
- Lorcaserin Extended-Release Tablets-Imodium A-D New Formula
- Lorcaserin Extended-Release Tablets-Imodium Multi-Symptom Relief